These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Singh BN; Collett JT; Chew CY Prog Cardiovasc Dis; 1980; 22(4):243-301. PubMed ID: 6986060 [No Abstract] [Full Text] [Related]
6. Bretylium tosylate: profile of the only available class III antiarrhythmic agent. Anderson JL Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143 [TBL] [Abstract][Full Text] [Related]
7. [Antiarrhythmic activity of adrenergic blockaders with different mechanisms of action]. Gendenshteĭn EI; Kostin IaV; Volkova ND Kardiologiia; 1977 Apr; 17(4):116-20. PubMed ID: 196133 [TBL] [Abstract][Full Text] [Related]
9. The development of new antidysrhythmic drugs. Williams EM Schweiz Med Wochenschr; 1973 Feb; 103(8):262-71. PubMed ID: 4144416 [No Abstract] [Full Text] [Related]
10. [Clinical experiences with bretylium tosylate]. Steffen V; Assmann I; Fiehring H Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213 [TBL] [Abstract][Full Text] [Related]
11. Effect of quinidine and bretylium on defibrillation energy requirements. Dorian P; Fain ES; Davy JM; Winkle RA Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282 [TBL] [Abstract][Full Text] [Related]
12. [Study of the electrophysiological properties of bretylium tosylate in man]. Touboul P; Porte J; Huerta F; Delahaye JP Arch Mal Coeur Vaiss; 1976 May; 69(5):503-11. PubMed ID: 821420 [TBL] [Abstract][Full Text] [Related]
13. The effect on intracellular atrial potentials of bretylium in relation to its local anaesthetic potency. Papp JG; Williams EM Br J Pharmacol; 1969 Feb; 35(2):P352-3. PubMed ID: 5774055 [No Abstract] [Full Text] [Related]
14. Drug corner: bretylium tosylate (Bretylol). Crit Care Nurse; 1980; 1(1):68-9. PubMed ID: 6914232 [No Abstract] [Full Text] [Related]
15. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate. Kabell G J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895 [TBL] [Abstract][Full Text] [Related]
16. [Bretylium tosylate as an anti-arrhythmic drug]. Steffen V; Fiehring H Z Gesamte Inn Med; 1976 Nov; 31(22):913-9. PubMed ID: 798429 [TBL] [Abstract][Full Text] [Related]
17. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium. Lucchesi BR Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion. Gibson JK; Stewart JR; Li YP; Lucchesi BR J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345 [TBL] [Abstract][Full Text] [Related]
19. Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane. Condouris GA; Ortiz J; Lyness W Eur J Pharmacol; 1979 Apr; 55(1):93-7. PubMed ID: 35358 [TBL] [Abstract][Full Text] [Related]
20. [Action of bretylium tosylate in a single bolus and in different doses on various electrophysiological parameters]. Chiariello M; Santinelli V; Ferro G; Stanislao M; Giunta A; Condorelli M Boll Soc Ital Cardiol; 1979; 24(7):747-51. PubMed ID: 554660 [No Abstract] [Full Text] [Related] [Next] [New Search]